Cargando…
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis
Albertsson P, Lennernäs B, Norrby K. Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis. APMIS 2011. Metronomic chemotherapy with cytotoxic agents has been shown to inhibit angiogenesis and, consequently, t...
Autores principales: | ALBERTSSON, PER, LENNERNäS, BO, NORRBY, KLAS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321228/ https://www.ncbi.nlm.nih.gov/pubmed/22229270 http://dx.doi.org/10.1111/j.1600-0463.2011.02830.x |
Ejemplares similares
-
Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?
por: Norrby, Klas
Publicado: (2014) -
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo
por: NORRBY, KLAS, et al.
Publicado: (2010) -
Rat Mesentery Angiogenesis Assay
por: Norrby, Klas C.
Publicado: (2011) -
VEGF stimulated the angiogenesis by promoting the mitochondrial functions
por: Guo, Dongqing, et al.
Publicado: (2017) -
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
por: Bocci, G, et al.
Publicado: (2008)